Short-term benefit of PRGF in BPTB ACL reconstruction; long-term effect not found .
Pain in donor site after BTB-ACL reconstruction with PRGF: a randomized trial
Arch Orthop Trauma Surg. 2016 Jun;136(6):829-3543 patients scheduled for anterior cruciate ligament reconstruction with a bone-patellar-tendon-bone autograft were randomized to undergo the procedure with or without administration of plasma rich in growth factors (PRGF) to the harvest sites. The purpose of this study was to evaluate if PRGF augmentation led to significantly reduced donor-site pain when compared to non-augmented procedures. Results demonstrated significantly lower pain scores in the PRGF group compared to the control group at 1 and 2 months postoperatively, but no significant differences between groups from 4 to 24 months postoperatively.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
